You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monitoring Neoadjuvant Chemotherapy Response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Boston (Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort, Diffuse Optical

Enrolling by invitation
  • Breast Cancer
  • Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort
  • Diffuse Optical Spectroscopy Imaging (DOSI) - Non-NAC Cohort
  • Boston, Massachusetts
    Boston Medical Center
Sep 20, 2022

Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast

Recruiting
  • Breast Cancer
  • Response monitoring
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 24, 2023

Shear and Strain Elastography in Monitoring Response to NAC in

Not yet recruiting
  • Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy Using SE and SWE
  • shear wave and strain elastography
  • (no location specified)
May 1, 2023

Using Diffuse Optical Spectroscopic Imaging

Withdrawn
  • Breast Cancer
  • Diffuse Optical Spectroscopy Imaging
  • Irvine, California
    Beckman Laser Institute
Oct 28, 2022

Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using

Recruiting
  • HER2 Negative Breast Cancer
  • Response monitoring (no intervention)
  • Albuquerque, New Mexico
    University of New Mexico Comprehensive Cancer Center
Apr 21, 2022

Soft Tissue Sarcomas and Osteosarcomas Using Diffuse Optical

Completed
  • Sarcoma
    • Irvine, California
      Beckman Laser Institute
    Oct 28, 2022

    Breast Cancer Trial in New York (Harmonic motion imaging)

    Recruiting
    • Breast Cancer
    • Harmonic motion imaging
    • New York, New York
      Columbia University Irving Medical Center/NYP
    Nov 7, 2022

    Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)

    Not yet recruiting
    • Inflammatory Breast Cancer
    • Breast conserving surgery
    • Radical modified mastectomy
    • (no location specified)
    Nov 14, 2023

    t Pathologic Complete Response Observed in HER2 Positive Breast

    Completed
    • HER2+ Breast Cancer
    • Rawalpindi, Punjab, Pakistan
      Rawalpindi Medical University
    Jun 26, 2023

    Breast Cancer Trial in Boston (DBT-TOBI, MRI-TOBI)

    Active, not recruiting
    • Breast Cancer
    • DBT-TOBI
    • MRI-TOBI
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Dec 21, 2022

    Breast Cancer Trial (Arm I (No PMRT), Arm II (PMRT))

    Not yet recruiting
    • Breast Cancer
    • Arm I (No PMRT)
    • Arm II (PMRT)
    • (no location specified)
    Aug 8, 2023

    Breast Cancer Female, Chemo Effect Trial in Milano (MAMMOT2)

    Recruiting
    • Breast Cancer Female
    • Chemotherapy Effect
    • MAMMOT2
    • Milano, Italy
      Ospedale San Raffaele
    Feb 22, 2021

    Breast Cancer Trial in Dallas (Digital Mammography, Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml)

    Active, not recruiting
    • Breast Cancer
    • Digital Mammography
    • Low Osmolar Contrast Material, 300-399 Mg/Ml Iodine Concentration, Per Ml
    • Dallas, Texas
      UT Southwestern Medical Center
    Jan 2, 2023

    DLCS for Predicting Neoadjuvant Chemotherapy Response

    Recruiting
    • Gastric Cancer
    • +4 more
    • develop and visualized a radio-clinical signatures from pretreatment oversampled CT images
    • Hangzhou, Zhejiang, China
      Cancer Hospital of the University of Chinese Academy of Sciences
    Nov 8, 2022

    Breast Cancer, Radiotherapy Trial in Bologna (SBRT anticipated boost)

    Recruiting
    • Breast Cancer
    • Radiotherapy
    • SBRT anticipated boost
    • Bologna, Italy
      IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Jan 9, 2023

    Within 1st Week of Chemotherapy Using Diffuse Optical

    Withdrawn
    • Breast Cancer
    • Diffuse Optical Spectroscopy Imaging
    • Costa Mesa, California
    • +2 more
    Oct 28, 2022

    Breast Cancer Trial in Gaia (Combined Aerobic and Resistance Exercise)

    Not yet recruiting
    • Breast Cancer
    • Combined Aerobic and Resistance Exercise
    • Gaia, Porto, Portugal
      Centro Hospitalar Vila Nova Gaia e Espinho
    Jul 27, 2023

    Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • Xiaopi granules
    • +2 more
    • (no location specified)
    Nov 22, 2023

    Breast Cancer Patients

    Completed
    • Neoadjuvant Chemotherapy
    • Neoadjuvant therapy
    • Istanbul, Turkey
      AcıbademAH
    Nov 21, 2023

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +8 more
    • Contrast-Enhanced Ultrasound
    • Perflutren Lipid Microspheres
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Apr 25, 2022

    Early Predict Pathological Complete Response to Neoadjuvant

    Recruiting
    • Breast Cancer
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Aug 8, 2022

      Gastric Cancer Trial in Fuzhou (response to neoadjuvant chemo)

      Completed
      • Gastric Cancer
      • response to neoadjuvant chemotherapy
      • Fuzhou, Fujian, China
        Department of Gastric Surgery
      Jul 15, 2022

      Breast Tumors Trial in Quebec City (Angiomammography)

      Recruiting
      • Breast Neoplasms
      • Angiomammography
      • Quebec City, Quebec, Canada
        St-Sacrement Hospital
      Jun 10, 2022

      Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course

      Not yet recruiting
      • Locally Advanced Rectal Carcinoma
      • Short course radiotherapy with concurrent capecitabine(825mg/m2)
      • Long course radiotherapy with concurrent capecitabine(825mg/m2)
      • (no location specified)
      Jun 24, 2023

      Disorder in Complete Remission in Response to Treatment Trial in Wuhan (Sintilimal Injection)

      Recruiting
      • Disorder in Complete Remission in Response to Treatment
      • Sintilimal Injection
      • Wuhan, Hubei, China
        Renmin Hospital of Wuhan University
      Sep 28, 2022